Lawrence Eichenfield

Lawrence Eichenfield

Director/Board Member at VERRICA PHARMACEUTICALS INC.

Net worth: - $ as of 31/07/2026

68 year
Commercial Services
Consumer Services
Health Technology

Profile

Lawrence F.
Eichenfield
is the founder of Pediatric Dermatology Research Alliance.
Current positions include Professor & Vice Chairman-Dermatology Department at UC San Diego School of Medicine since 2009, Director at American Dermatological Association, Inc., and Independent Director at Verrica Pharmaceuticals, Inc. since 2020.
Former roles include President & Director at American Acne & Rosacea Society, Director at Forte Biosciences, Inc., Director at American Academy of Dermatology from 2005 to 2009, Independent Director at Forte Biosciences, Inc. from 2020 to 2024, Member of Alpha Omega Alpha Honor Medical Society, and President of Society For Pediatric Dermatology from 2002 to 2003.
Education includes undergraduate studies at Icahn School of Medicine at Mount Sinai.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
05/06/2026 0 ( -.--% ) - $ 31/07/2026

Lawrence Eichenfield active positions

CompaniesPositionStart
VERRICA PHARMACEUTICALS INC. Director/Board Member 01/07/2020
Director/Board Member -
Corporate Officer/Principal 01/01/2009

Former positions of Lawrence Eichenfield

CompaniesPositionEnd
FORTE BIOSCIENCES, INC. Director/Board Member 17/09/2024
Chairman -
President 01/01/2003
Corporate Officer/Principal -
Founder -
See the detail of Lawrence Eichenfield's experience

Training of Lawrence Eichenfield

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

60

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Consumer Services

Commercial Services

Commercial Services

Commercial Services

American Acne & Rosacea Society

Consumer Services

Health Technology

Health Services

Health Technology

Commercial Services

Commercial Services

  1. Stock Market
  2. Insiders
  3. Lawrence Eichenfield